Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers.

Zhang, Tian-Wei; Zhang, Peng; Nie, Dong; Che, Xin-Yu; Fu, Tian-Tai; Zhang, Yan.

Afiliação

Zhang TW; Department of Hematology and Radiotherapy, Zibo 148 Hospital, Zibo 255300, Shandong Province, China.
Zhang P; Department of Hematology and Radiotherapy, Zibo 148 Hospital, Zibo 255300, Shandong Province, China.
Nie D; Department of Hematology and Radiotherapy, Zibo 148 Hospital, Zibo 255300, Shandong Province, China.
Che XY; Department of Hematology and Radiotherapy, Zibo 148 Hospital, Zibo 255300, Shandong Province, China.
Fu TT; Department of Hematology and Radiotherapy, Zibo 148 Hospital, Zibo 255300, Shandong Province, China.
Zhang Y; Department of Hematology and Radiotherapy, Zibo 148 Hospital, Zibo 255300, Shandong Province, China. zhangyan100862023@163.com.

World J Gastrointest Oncol ; 15(7): 1262-1270, 2023 Jul 15.

Article em En | MEDLINE | ID: mdl-37546558